医疗设备制造商Enovis Corporation（股票代码：ENOV）周四盘中股价大幅下挫，跌幅高达9.46%。这一显著跌幅主要源于公司下调了2025年的利润预期。
根据Enovis最新公告，公司将2025年每股收益预期从此前的3.10美元至3.25美元区间下调至2.95美元至3.10美元区间。尽管公司同时上调了2025年的营收预期，从原先的21.9亿美元至22.2亿美元提高到22.2亿美元至22.5亿美元，但投资者似乎更关注利润预期的下调。这一调整反映出公司对未来盈利能力的谨慎态度，引发了市场的担忧。
值得注意的是，Enovis第一季度的表现仍然亮眼。公司报告称，第一季度调整后每股收益达到0.81美元，超过分析师预期的0.74美元。然而，这一短期利好似乎无法抵消投资者对公司长期盈利能力的担忧。此外，券商Evercore ISI指出，Enovis股价表现不佳可能与关税担忧有关，这表明除了公司自身因素外，外部经济环境的不确定性也在影响投资者信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.